A liver cancer PDX standardization model base
Patent Information
- Authority / Receiving Office
- CN Β· China
- Current Assignee / Owner
- WEST CHINA HOSPITAL SICHUAN UNIV
- Publication Date
- 2016-06-22
- Estimated Expiration
- Not applicable Β· inactive patent
Abstract
Description
technical field
[0001] The invention belongs to the field of biomedicine and relates to a liver cancer PDX standardized model library. Background technique
[0002] PDX (Patient-Derivedtumor Xenograft) human-derived tumor xenograft model refers to the transplantation of fresh tumor tissues from patients into immunodeficient mice, and relies on the microenvironment provided by the mice for growth. Compared with human tumor cell line models, the degree of differentiation, morphological characteristics, structural characteristics and molecular characteristics of PDX model tumors are closer to the characteristics of human tumors, which provides great opportunities for the biological research of tumors, the search for diagnostic markers and Drug screening provides an important in vivo model. In addition, the PDX model can reflect the characteristics of the patient's own tumor from which the specimen was derived, including the specificity of drug response. Therefore, PDX models ...